RxDoctor Payments Data

Harold Rabinovitz, MD

MOHS-Micrographic Surgery · Raleigh, NCNPI 1093710618

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Almirall LLC at 34.0% of the total. 2025 is the largest year on record at $180, 6.6 times the $27 reported in 2019. That places this record below the midpoint for mohs-micrographic surgery clinicians in NC, where the typical reported total is $1,161.

$623in general payments, 2019–2025

Across 18 payments — averaging $34.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Almirall LLC$212
  • Regeneron Healthcare Solutions, Inc.$162
  • UCB, Inc.$44
  • Amgen$34
  • Incyte Corporation$28
  • DUSA Pharmaceuticals, Inc.$27
  • plus $116 from 6 others

What the payments were for

  • Food & beverage$623100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$623 in reported general payments places this provider in the 35th percentile of 50 mohs-micrographic surgery providers in North Carolina.

See all mohs-micrographic surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$95,807
Medicare patients
339
Services billed
1,156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil26$1,699
Calcipotriene14$1,075
Mupirocin45$281
Triamcinolone Acetonide51$183

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →